UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO Quant / Systematic

CIK: 0001019231 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 6, 2021

Total Value ($000): $130,363 (100.0% shares, 0.0% debt)

Holdings (18)

TSHA TAYSHA GENE THERAPIES INC 22.6%

Value ($000) $29,493 Shares 1,391,190 Est. Cost $23.82 Unrealized -3.2%

BEAM BEAM THERAPEUTICS INC 22.2%

Value ($000) $28,881 Shares 224,391 Est. Cost $95.13 Unrealized -16.2%

— ELLIOTT OPPORTUNITY II CORP 15.4%

Value ($000) $20,020 Shares 2,000,000 Est. Cost $10.01 Unrealized —

VT VANGUARD TOTAL WORLD STOCK ETF 12.6%

Value ($000) $16,421 Shares 158,484 Est. Cost $80.77 Unrealized —

— CODIAK BIOSCIENCES INC 12.0%

Value ($000) $15,697 Shares 847,108 Est. Cost $15.08 Unrealized —

IMTX IMMATICS NV 6.2%

Value ($000) $8,097 Shares 697,431 Est. Cost $10.53 Unrealized +11.5%

TXN TEXAS INSTRUMENTS INC 4.7%

Value ($000) $6,154 Shares 32,000 Est. Cost $57.24 Unrealized +186.9%

— AEGLEA BIOTHERAPEUTICS INC 1.4%

Value ($000) $1,876 Shares 269,578 Est. Cost $6.41 Unrealized —

— SOLITON INC 1.3%

Value ($000) $1,687 Shares 75,000 Est. Cost $10.98 Unrealized —

— PLX PHARMA INC 0.7%

Value ($000) $865 Shares 62,673 Est. Cost $6.14 Unrealized —

— PIONEER NATURAL RESOURCES CO 0.5%

Value ($000) $594 Shares 3,656 Est. Cost $162.47 Unrealized —

— TFF PHARMACEUTICALS INC 0.2%

Value ($000) $212 Shares 22,066 Est. Cost $18.47 Unrealized —

LXRX LEXICON PHARMACEUTICALS INC 0.1%

Value ($000) $164 Shares 35,714 Est. Cost $7.34 Unrealized -34.4%

— APOLLO ENDOSURGERY INC 0.1%

Value ($000) $126 Shares 15,601 Est. Cost $2.24 Unrealized —

WY WEYERHAEUSER CO 0.0%

Value ($000) $34 Shares 1,000 Est. Cost $30.53 Unrealized 0.0%

AAPL APPLE INC 0.0%

Value ($000) $27 Shares 200 Est. Cost $126.45 Unrealized 0.0%

UNH UNITEDHEALTH GROUP INC 0.0%

Value ($000) $10 Shares 25 Est. Cost $369.03 Unrealized 0.0%

POR PORTLAND GENERAL ELECTRIC CO 0.0%

Value ($000) $5 Shares 118 Est. Cost $20.00 Unrealized +101.7%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
TSHA	TAYSHA GENE THERAPIES INC	1,391,190	$29,493	22.6%	$23.82	-3.2%	COM	877619106
BEAM	BEAM THERAPEUTICS INC	224,391	$28,881	22.2%	$95.13	-16.2%	COM	07373V105
—	ELLIOTT OPPORTUNITY II CORP	2,000,000	$20,020	15.4%	$10.01	—	COM	G30092129
VT	VANGUARD TOTAL WORLD STOCK ETF	158,484	$16,421	12.6%	$80.77	—	ETFS	922042742
—	CODIAK BIOSCIENCES INC	847,108	$15,697	12.0%	$15.08	—	COM	192010106
IMTX	IMMATICS NV	697,431	$8,097	6.2%	$10.53	+11.5%	COM	N44445109
TXN	TEXAS INSTRUMENTS INC	32,000	$6,154	4.7%	$57.24	+186.9%	COM	882508104
—	AEGLEA BIOTHERAPEUTICS INC	269,578	$1,876	1.4%	$6.41	—	COM	00773J103
—	SOLITON INC	75,000	$1,687	1.3%	$10.98	—	COM	834251100
—	PLX PHARMA INC	62,673	$865	0.7%	$6.14	—	COM	72942A107
—	PIONEER NATURAL RESOURCES CO	3,656	$594	0.5%	$162.47	—	COM	723787107
—	TFF PHARMACEUTICALS INC	22,066	$212	0.2%	$18.47	—	COM	87241J104
LXRX	LEXICON PHARMACEUTICALS INC	35,714	$164	0.1%	$7.34	-34.4%	COM	528872302
—	APOLLO ENDOSURGERY INC	15,601	$126	0.1%	$2.24	—	COM	03767D108
WY	WEYERHAEUSER CO	1,000	$34	0.0%	$30.53	0.0%	COM	962166104
AAPL	APPLE INC	200	$27	0.0%	$126.45	0.0%	COM	037833100
UNH	UNITEDHEALTH GROUP INC	25	$10	0.0%	$369.03	0.0%	COM	91324P102
POR	PORTLAND GENERAL ELECTRIC CO	118	$5	0.0%	$20.00	+101.7%	COM	736508847